Michele Antonelli was appointed President of Stallergenes SAS and Executive Vice President, Head of Europe & International at Stallergenes-Greer in 2016. Michele has more than 20 years of international experience in the biopharmaceutical industry, with extensive expertise in both manufacturing and commercial. He joined Stallergenes SAS in November 2015 as Executive Vice President, Head of International Operations. Michele previously worked at UCB, where he held roles of various responsibility and scope, most recently serving as Executive Vice President and Head of lmmunology Europe, overseeing the region’s commercial, medical, and market access activities. Prior to joining UCB, Michele spent 16 years at Merck Serono, ultimately serving as Senior Vice President and Global Head of Biotech Manufacturing and Process Development.